COMPARISON OF INTRAVITREAL INJECTION OF RANIBIZUMAB VERSUS LASER THERAPY FOR ZONE II TREATMENT-REQUIRING RETINOPATHY OF PREMATURITY

PURPOSE: To compare the efficacy of intravitreal injection of ranibizumab (IVR) monotherapy and laser therapy for treatment-requiring retinopathy of prematurity (ROP) in Zone II. METHODS: A prospective, randomized, controlled single-center trial was applied from January 2014 to December 2014; infant...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Retina
Autors principals: Zhang, Guoming, Yang, Mingmin, Zeng, Jian, Vakros, Georgios, Su, Kangjin, Chen, Miaohong, Li, Huilin, Tian, Ruyin, Li, Na, Tang, Song, He, Honghui, Tan, Wenjing, Song, Xiangmei, Zhuang, Runsen
Format: Artigo
Idioma:Inglês
Publicat: Retina 2017
Matèries:
Original Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5388026/
https://ncbi.nlm.nih.gov/pubmed/27529839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/IAE.0000000000001241
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars